FDA Inspection 1164793 — Rhode Island Blood Center, a Division of New York Blood Center, Inc. South County Donor Center

Rhode Island Blood Center, a Division of New York Blood Center, Inc. South County Donor Center — FEI 3003126020

The FDA completed an inspection of Rhode Island Blood Center, a Division of New York Blood Center, Inc. South County Donor Center on March 16, 2022 in Narragansett, RI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 16, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Narragansett, RI (United States)